rs189947237
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_001292063.2(OTOG):c.1353C>A(p.Phe451Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000174 in 1,550,424 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001292063.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOG | ENST00000399397.6 | c.1353C>A | p.Phe451Leu | missense_variant | Exon 13 of 56 | 5 | NM_001292063.2 | ENSP00000382329.2 | ||
OTOG | ENST00000399391.7 | c.1389C>A | p.Phe463Leu | missense_variant | Exon 12 of 55 | 5 | ENSP00000382323.2 | |||
OTOG | ENST00000498332.5 | n.1259C>A | non_coding_transcript_exon_variant | Exon 12 of 16 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000414 AC: 63AN: 152136Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000623 AC: 93AN: 149342Hom.: 2 AF XY: 0.000622 AC XY: 50AN XY: 80390
GnomAD4 exome AF: 0.000147 AC: 206AN: 1398170Hom.: 3 Cov.: 31 AF XY: 0.000132 AC XY: 91AN XY: 689624
GnomAD4 genome AF: 0.000414 AC: 63AN: 152254Hom.: 0 Cov.: 32 AF XY: 0.000470 AC XY: 35AN XY: 74446
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
The F463L variant in the OTOG gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The F463L variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The F463L variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is conserved in mammals, however, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret F463L as a variant of uncertain significance. -
p.Phe463Leu in exon 12 of OTOG: This variant is not expected to have clinical si gnificance because it has been identified in 0.8% (95/11746) of East Asian chrom osomes including 2 homozygotes by the Genome Aggregation Database (gnomAD, http: //gnomad.broadinstitute.org; dbSNP rs189947237). -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at